Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Ongoing discussions with the FDA regarding nrSPMS application have indicated ...
Cathie Wood, head of Ark Investment Management, often buys stocks when they dip and sells after strong runs. She recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback